324 related articles for article (PubMed ID: 16304585)
41. Onchodermatitis.
Murdoch ME
Curr Opin Infect Dis; 2010 Apr; 23(2):124-31. PubMed ID: 20071985
[TBL] [Abstract][Full Text] [Related]
42. Onchocerciasis control: the APOC strategy.
Dadzie KY
Afr Health; 1997 Mar; 19(3):13-5. PubMed ID: 12292398
[TBL] [Abstract][Full Text] [Related]
43. The Onchocerciasis Control Programme in West Africa (OCP).
Boatin B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
[TBL] [Abstract][Full Text] [Related]
44. The challenge of establishing community-directed treatment with Mectizan in Uganda.
Okwero P
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
[TBL] [Abstract][Full Text] [Related]
45. [Partnerships and the distribution of Mectizan. The role of a non-governmental development organization in a country with endemic onchocerciasis].
Godin C
Sante; 1998; 8(1):62. PubMed ID: 9592883
[No Abstract] [Full Text] [Related]
46. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC).
Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252
[TBL] [Abstract][Full Text] [Related]
47. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
48. [Onchocerciasis control in Senegal: evaluation of 10 years of control].
Diawara L
Sante; 1998; 8(1):32-6. PubMed ID: 9592874
[No Abstract] [Full Text] [Related]
49. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).
Amazigo UV; Obono M; Dadzie KY; Remme J; Jiya J; Ndyomugyenyi R; Roungou JB; Noma M; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S75-92. PubMed ID: 12081253
[TBL] [Abstract][Full Text] [Related]
50. [Launching of mass treatment of onchocerciasis].
Toufic N
Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1989; 66(3-4):173-83. PubMed ID: 2488664
[TBL] [Abstract][Full Text] [Related]
51. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
[TBL] [Abstract][Full Text] [Related]
52. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
53. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
54. River blindness.
Unnasch TR
Lancet; 2002 Jul; 360(9328):182-3. PubMed ID: 12133647
[No Abstract] [Full Text] [Related]
55. Onchocerciasis: elimination is feasible.
Wkly Epidemiol Rec; 2009 Sep; 84(37):382-3. PubMed ID: 19764128
[No Abstract] [Full Text] [Related]
56. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
57. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).
Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248
[TBL] [Abstract][Full Text] [Related]
58. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
Amazigo U; Noma M; Boatin BA; Etya'alé DE; Sékétéli A; Dadzie KY
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S23-31. PubMed ID: 9861264
[TBL] [Abstract][Full Text] [Related]
59. Ten years of NGDO action against river blindness.
Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
[TBL] [Abstract][Full Text] [Related]
60. [Human onchocerciasis in Africa].
Boussinesq M
Med Trop (Mars); 1997; 57(4):389-400. PubMed ID: 9612783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
